期刊文献+

EGFR、P16、Ki67和P53在宫颈鳞状上皮内瘤变和宫颈鳞状细胞癌中表达的临床意义 被引量:10

Expression and its clinical significance of EGFR、P16、Ki67 and P53 in cervical intraepithelial neoplasia and cervical squamous cell carcinoma
暂未订购
导出
摘要 目的探讨EGFR、P16、Ki67和P53在宫颈病变组织中的表达及临床意义。方法应用免疫组化SP法检测84例宫颈鳞状上皮内瘤变(CIN)和30例宫颈鳞癌中EGFR、P16、Ki67和P53的表达,另选取20例正常宫颈组织作为对照。结果 EGFR、P16、Ki67和P53在正常宫颈组织中阳性率分别为10.00%、0、5.00%及5.00%;在CIN中阳性率分别为33.33%、82.14%、54.76%及47.62%;在宫颈鳞癌中阳性率分别为56.67%、100.00%、86.67%及76.67%,差异均有统计学意义(P<0.05)。EGFR、P16、Ki67和P53表达强度均随宫颈病变的进展而增加,表达均有统计学意义(P<0.05)。EGFR、P16、Ki67和P53表达在CIN和鳞癌中两两比较均呈显著性正相关(P<0.05)。结论 EGFR、P16、Ki67和P53可能参与了宫颈癌病变的发生及发展,联合检测四者可作为CIN分级与鳞癌诊断的重要参考指标。 Objective To investigate the clinicopathologic significance of the expression of EGFR,P16,Ki67 and P53 proteins in cervical lesion tissues. Methods To detect the expression of EGFR,P16,Ki67 and P53 proteins in 20 nor- mal uterine cervix, 84 cervical intraepithelial neoplasia (CIN) and 30 cervical squamous cell carcinoma by immunohis- toehemical method. Results The positive expression rates of EGFR,P16,Ki67 and P53 were 10.00%, O, 5.00% and 5.00% in normal uterine cervix. The positive expression rates of EGFR,P16,Ki67 and P53 were 33.33% ,82.14%, 54.76% and 47.62% in CIN. The positive expression rates of EGFR,P16,Ki67 and P53 were 56.67% ,100.00%, 86.67% and 76.67% in cervical squamous cell carcinoma. The significant differences statistically of EGFR,P16 ,Ki67 and P53 proteins expression in normal uterine cervix, CIN and cervical squamous cell carcinoma were observed(P 〈 0.05). The positive expression rates of EGFR,PI6 ,Ki67 and P53 increased with the progression of cervical neoplasia. All groups had statistical difference (P 〈 0.05 ). EGFR,P16 ,Ki67 and P53 expression was positively associated with each other (P 〈 0.05). Conclusion EGFR,P16,Ki67 and P53 expression may be involved in the occurrence and devel- opment of cervical lesions.Combined detection of the four proteins can be used as the CIN classification and diagnosis of cervical squamous cell carcinoma of the important reference index.
出处 《中国现代医生》 2013年第2期87-90,共4页 China Modern Doctor
关键词 宫颈上皮内瘤变 宫颈鳞癌 EGFR P16 KI67 P53 免疫组织化学 Cervical intraepithelial neoplasia Cervical squamous cell carcinoma EGFR P16 Ki67 P53 Immunohis-tochemistry
  • 相关文献

参考文献17

  • 1Sharma SV,Bell DW,Settleman J ,el al. Epidermal growth factor reeep tur mutations in lung cancer[J]. Nat Rev Cancer,2007,7(3) : 169-181.
  • 2Brustmann H. Epidermal growth factor receptor expression in serous ovarian carcinoma:an immunohislochemieal study with galeetin-3 and cyclin DI and uutcome[J], hat J Gynecol Pathol,2008,27(3):380-389.
  • 3王珏.EGFR和p16在宫颈上皮内瘤变及宫颈癌中的表达[J].交通医学,2009,23(6):613-614. 被引量:5
  • 4冯淑瑜,张彦娜,刘继红,刘建刚,严鸣.宫颈癌和宫颈上皮内瘤变中表皮生长因子受体表达与人乳头瘤病毒16和(或)18感染及其相互关系[J].中华肿瘤杂志,2007,29(10):759-763. 被引量:10
  • 5Mathur SP, Mathur RS, Rust PF,et al. Human papilloma virus (HPV) -E6/E7 and epidermal growth factor reeeptur(EGFR)protein levels in cervical cancer and cervical intraepithelial neoplasia(ClN)[J].Am J Reprod hnmuno1,2001,46(4) :280-287.
  • 6Lee ES,Kim LH,Abdullah WA,et al. Expression and alteration of P16 in diffuse large B cell lymphoma.[J]. Pathobinlogy,2010,77 (2): 96-105.
  • 7程淑霞.赵先兰.子官颈癌及上皮内瘤变中高危型HPV感染与p16INK4A、PTEN蛋F1表达的关系[D].郑州大学,2007.
  • 8董磊,宋张娟.宫颈鳞癌中p16、p21^(WAF1)、Rb、cyclinE蛋白的表达[J].临床与实验病理学杂志,2004,20(5):554-556. 被引量:16
  • 9Salit IE,Tinmouth J,Chnng S,et al. Screening for HIV-associated anal cancer:correlation of HPV genotypes, PI 6,and E6 transcripts with anal pathology[J]. Cancer Epidemiol Biomarkers Prey, 2009,18 (7) : 1986-1992.
  • 10Beenken SW,Bland KI. Biomarkers for breast cancer[J]. Minerva Chir, 2002,57 (4) :437-448.

二级参考文献66

  • 1倪凤云,张梅月.子宫颈癌发病年轻化临床回顾性分析[J].实用诊断与治疗杂志,2004,18(4):337-338. 被引量:16
  • 2郭东辉,刘智慧,范幼奇,王颖.p16、cyclin E在宫颈鳞状上皮病变诊断中的应用[J].诊断病理学杂志,2004,11(3):162-163. 被引量:10
  • 3周咏梅,李庭芳.CyclinD1和P16在宫颈上皮内瘤变及宫颈鳞癌中的表达及其意义[J].新疆医科大学学报,2005,28(7):658-660. 被引量:7
  • 4Rostad B,Schei B,Da Costa F.Risk factors for cervical cancer in Mozambican women[J].Int J Gynecol Obstet,2003,80(1): 63-65.
  • 5Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involveol in genesis of many tumor types[J]. Science, 1994,264(5157):436-440.
  • 6Meijer CJ, Snijders PJ, yam den Brule AJ. Screening for cervical cancer: Should we test for infection with high - risk HPV? [J]. CMAJ, 2000,163(5): 535 -538.
  • 7Hunter T, Pines J. Cyclins and cancer Ⅱ: cyclin D and CDK inhibitors come of age [ J ]. Cell, 1994,79 ( 5 ) :573 - 582.
  • 8Bae DS, Cho SB, Kim YJ,et al. Aberrant expression of cyclin D1 is associate with poor prognosis in carly stage cervical of the utcrus[ J I. Gynccol Oncol, 2001,81 (3) : 341 - 347.
  • 9Silva SD, Agostini M, Nishimoto IN, et al. Expression of fatty acid synthase, ErbB2 and Ki -67 in head and neck squamous cell carcinma. A clinicopathological study [ J ]. Oral Oncol, 2004,40 (7) .688 - 696.
  • 10Beenken SW, Bland KI. Biomarkers for breast cancer [J].Minerva Chir,2002,57 ( 4 ) :437 - 448.

共引文献82

同被引文献124

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部